FEEDBACK
Jump to content

Organisation

The Lancet Infectious Diseases

International medical journal focusing in infectious diseases
International medical journal focusing on infectious diseases.

The website includes full content of the current journal, searchable back issues, links to other sites and a news service. Although many articles are of a medical, scientific nature, the journal often contains work of significance to health and HIV/AIDS workers beyond the purely medical.

Users need to register but most papers can be downloaded free.

Published Documents

Items 1 to 10

Treating children with multidrug-resistant tuberculosis yields success rates at least as good as those reported for adults
D. Ettehad; H.S. Schaaf; J.A. Seddon / The Lancet Infectious Diseases, 2012
This paper aims to assess existing evidence for the treatment of multidrug-resistant (MDR) tuberculosis in children. It highlights that MDR clinical management is especially challenging because there is much variation in the...
Investing in how best to make safe hygiene practices matters of daily routine
V. Curtis; W. Schmidt; S. Luby / The Lancet Infectious Diseases, 2011
Evidence shows the benefit of improved hygiene (e.g. improved hand-washing and safe stool disposal). However, although promotion of safe hygiene is the single most cost-effective means of preventing infectious disease, investment in h...
The role of mobile phones in in the scale-up of global health systems
Richard Lester; Sarah Karanja / The Lancet Infectious Diseases, 2008
This article, published by The Lancet, argues that with mobile telephones reaching people in Africa’s cities, towns, villages, and countrysides more rapidly than anywhere else in the world, they are perhaps one of the most promi...
Which water, sanitation and hygiene interventions are most effective?
L. Fewtrell; R.B. Kaufmann; D. Kay / The Lancet Infectious Diseases, 2005
This article, published in the Lancet Infectious Diseases, reviews and analyses the evidence on effectiveness of interventions to reduce illness through improvements in drinking water, sanitation facilities, and hygiene practices in d...
Five strategies to improve global tuberculosis control
S.M. Blower; C.L. Daley / The Lancet Infectious Diseases, 2002
One of the operational goals of the Stop-TB partnership movement is based on World Health Organization (WHO)-determined targets to detect, by 2005, 70 per cent of new smear-positive cases under DOTS, and to successfully treat 85 per c...
Interview with the Chief Scientific Officer of Medicines for Malaria venture – a public-private partnership
P. Das / The Lancet Infectious Diseases, 2002
Robert George Ridley is the Chief Scientific Officer of the Medicines for Malaria venture (MMV)—a not-for-profit public-private partnership to discover and develop new antimalarials for use in disease-endemic countries. This arti...
Abstinence programmes do not address broader factors in sexual behaviour
T. Barnett; J. Parkhurst / The Lancet Infectious Diseases, 2005
This opinion piece, published by Lancet Infectious Diseases, argues that an abstinence approach to HIV does not take into account the balance between contextual and environmental factors and individual choices in determining why and h...
Estimating childhood mortality from acute respiratory infections: what do verbal autopsies tell us?
B.G. Williams; E. Gouws; C. Boschi-Pinto; J. Bryce / The Lancet Infectious Diseases, 2002
Acute respiratory infections (ARI) are among the leading causes of childhood mortality in poor countries. It is important to estimate reliably the number of children worldwide who die from ARI and to understand how and why this varies...
On high alert: success of a global surveillance system for infectious diseases
I. Arita; M. Nakane; K. Kojima; N. Yoshihara / The Lancet Infectious Diseases, 2004
This article, published in The Lancet Infectious Diseases, examines the effectiveness of a sentinel surveillance system targeting selected infectious diseases across South America, Africa and Asia. This system, developed by the Agency...
Key elements of the South African programme to provide antiretroviral drug treatment
C. Kerr / The Lancet Infectious Diseases, 2004
This short article presents the main features of the a South African major plan to provide antiretroviral (ARV) drugs to hundreds of thousands of HIV-infected patients. Findings include: about 50 000 people could...
Items 1 to 10

Authors

C. Kerr

Focus Countries

Geographic focus

Amend this organisation

Help us improve and keep up-to-date